Resource centre

Main menu

217 results

Phasing

Publication
ZCWPW1 loss-of-function variants in Alzheimer’s Disease
August 13 2021
Workflow
Workflow overview: pharmacogenomics with adaptive sampling
August 5 2025
Workflow
Workflow overview: human variant calling
April 29 2025
Video
Parent-of-origin-aware genomic analysis infers segregation of pathogenic variants
June 26 2023
Publication
Verkko2: integrating proximity ligation data with long-read De Bruijn graphs for efficient telomere-to-telomere genome assembly, phasing, and scaffold
December 26 2024
Video
Variant segregation in rare disease singletons and duos using nanopore adaptive sampling
September 27 2023
Video
Variant phasing for antisense oligonucleotide design using adaptive sampling
May 19 2025
Publication
Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci
June 25 2020
Video
Using ultra-long-read Oxford Nanopore sequencing to detect complex structural variants in leukaemia
May 19 2025
Video
Using Targeted Nanopore Technologies
January 27 2021
Video
Using Oxford Nanopore sequencing in grapevine breeding
May 24 2024
Poster
Unprecedented access to haplotype-resolved biology enabled by ultra-long reads and Pore-C
May 15 2023
Video
Unlocking the banana pangenome: harnessing genetic diversity
May 24 2024
Poster
Unlocking the power of haplotype-based molecular breeding using long read DNA sequencing
May 19 2023
Case study
Case study: understanding the drivers of oncogenesis
September 14 2023
Publication
Ultrarapid and high-resolution HLA class I typing using transposase-based nanopore sequencing applied in pharmacogenetic testing
June 23 2023
Video
Ultra-rich human data — variant analysis with EPI2ME
September 17 2024
Publication
Ultra-long sequencing for contiguous haplotype resolution of the human immunoglobulin heavy chain locus
December 17 2024
Video
Transforming cancer care: redefining cancer characterization and predisposition insights through nanopore sequencing
September 17 2024
Publication
The utility of long-read sequencing in diagnosing early-onset Parkinson's disease
December 19 2024

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

ZCWPW1 loss-of-function variants in Alzheimer’s Disease

Workflow overview: pharmacogenomics with adaptive sampling

Workflow overview: human variant calling

Parent-of-origin-aware genomic analysis infers segregation of pathogenic variants

Verkko2: integrating proximity ligation data with long-read De Bruijn graphs for efficient telomere-to-telomere genome assembly, phasing, and scaffold

Variant segregation in rare disease singletons and duos using nanopore adaptive sampling

Variant phasing for antisense oligonucleotide design using adaptive sampling

Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci

Using ultra-long-read Oxford Nanopore sequencing to detect complex structural variants in leukaemia

Using Targeted Nanopore Technologies

Using Oxford Nanopore sequencing in grapevine breeding

Unprecedented access to haplotype-resolved biology enabled by ultra-long reads and Pore-C

Unlocking the banana pangenome: harnessing genetic diversity

Unlocking the power of haplotype-based molecular breeding using long read DNA sequencing

Case study: understanding the drivers of oncogenesis

Ultrarapid and high-resolution HLA class I typing using transposase-based nanopore sequencing applied in pharmacogenetic testing

Ultra-rich human data — variant analysis with EPI2ME

Ultra-long sequencing for contiguous haplotype resolution of the human immunoglobulin heavy chain locus

Transforming cancer care: redefining cancer characterization and predisposition insights through nanopore sequencing

The utility of long-read sequencing in diagnosing early-onset Parkinson's disease

shared.filter

Products

Research areas

Techniques